Hepatic apolipoprotein A-I, C-III and E mRNA expressions in human parenchymal liver diseases

Noriko Fukushima, Kyosuke Yamamoto, Iwata Ozaki, Toshihiko Mizuta, Susumu Kajihara, Yoichi Setoguchi, Takahiro Sakai
{"title":"Hepatic apolipoprotein A-I, C-III and E mRNA expressions in human parenchymal liver diseases","authors":"Noriko Fukushima,&nbsp;Kyosuke Yamamoto,&nbsp;Iwata Ozaki,&nbsp;Toshihiko Mizuta,&nbsp;Susumu Kajihara,&nbsp;Yoichi Setoguchi,&nbsp;Takahiro Sakai","doi":"10.1016/0928-4346(96)00304-0","DOIUrl":null,"url":null,"abstract":"<div><p>In order to understand the mechanism underlying in dyslipoproteinemia accompanied with liver diseases, levels in apolipoproteins A-I, C-III and E mRNA expressions in various human parenchymal liver diseases were assessed by Northen blot analysis. The mRNA expressions were significantly decreased in liver cirrhosis and acute hepatitis as compared with controls and were correlated with serum albumin levels. This finding indicates that liver biosynthesis of these apolipoproteins is suppressed in parenchymal human liver disease. This could be one of the mechanisms causing the dyslipoproteinemia in the liver diseases. This is the first study to show decreased apolipoprotein gene expression in human parenchymal liver diseases.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":"5 4","pages":"Pages 244-250"},"PeriodicalIF":0.0000,"publicationDate":"1996-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0928-4346(96)00304-0","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Hepatology Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0928434696003040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In order to understand the mechanism underlying in dyslipoproteinemia accompanied with liver diseases, levels in apolipoproteins A-I, C-III and E mRNA expressions in various human parenchymal liver diseases were assessed by Northen blot analysis. The mRNA expressions were significantly decreased in liver cirrhosis and acute hepatitis as compared with controls and were correlated with serum albumin levels. This finding indicates that liver biosynthesis of these apolipoproteins is suppressed in parenchymal human liver disease. This could be one of the mechanisms causing the dyslipoproteinemia in the liver diseases. This is the first study to show decreased apolipoprotein gene expression in human parenchymal liver diseases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肝载脂蛋白A-I、C-III和E mRNA在人实质性肝病中的表达
为了了解脂蛋白异常血症伴发肝脏疾病的发病机制,我们采用Northen blot方法检测了人各种实质肝脏疾病中载脂蛋白A-I、C-III和E mRNA的表达水平。与对照组相比,肝硬化和急性肝炎患者mRNA表达显著降低,且与血清白蛋白水平相关。这一发现表明,在实质性人肝病中,这些载脂蛋白的肝脏生物合成受到抑制。这可能是导致肝病患者脂蛋白异常血症的机制之一。这是第一个在人实质肝脏疾病中显示载脂蛋白基因表达降低的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Author index Subject index Clinical usefulness of serum HBV DNA measurement with a non radioactive chemiluminescence method A new point mutation in cholinesterase: relationship between multiple mutation sites and enzyme activity The changes of serum soluble HLA-class I and CD8 concentrations during interferon treatment of chronic hepatitis C patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1